Hope restored: The critical role that Minimal Residual Disease can play in blood cancer patient care

Yi Zhou

Chief Technical Officer

Yi Zhou is the Chief Technical Officer of Adaptive Biotechnologies, a commercial-stage biotech company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease. Yi is a proven leader with successful experience building world-class organizations, with over 25 years of experience leading IT in a global environment, building enterprise systems, data analytics platforms and highly regulated medical device products. Before joining Adaptive, Yi led a variety of large-scale digital health initiatives at GE Healthcare and won the GE CEO award. Prior to that, Yi took on various senior leadership roles at Quest Diagnostics and Celera. Yi holds two master’s degrees – Microbiology from the University of Kansas and Computer Science from the University of Missouri. Yi also has a bachelor’s degree in Microbiology from Fudan University and four professional certificates in Agile process and software development.